Login to your account
Don’t have an account?
Create a Free Account
x
Filter:
Filters applied
- EMAS Position Statements and Clinical Guides
- Palacios, SantiagoRemove Palacios, Santiago filter
Author
- Rees, Margaret3
- Erel, C Tamer2
- Lambrinoudaki, Irene2
- Schenck-Gustafsson, Karin2
- Tremollieres, Florence2
- Birkhauser, Martin1
- Borrego, Rafael Sanchez1
- Brincat, Mark1
- Castelo-Branco, Camil1
- Ceausu, Iuliana1
- Currie, Heather1
- Depypere, Herman1
- Gambacciani, Marco1
- Llaneza, Placido1
- Mijatovic, Velja1
- Moen, Mette H1
- Nappi, Rossella E1
- Neves-e-Castro, Manuel1
- Pérez-López, Faustino R1
- Rozenberg, Serge1
- Samsioe, Goran1
- Simon, James1
- Simoncini, Tommaso1
- Vujovic, Svetlana1
Keyword
- Menopausal hormone therapy2
- Bazedoxifene1
- Genitourinary syndrome of menopause1
- Hot flushes1
- Lasofoxifene1
- Menopause1
- Nonhormonal vaginal therapy1
- Osteoporosis1
- Postmenopausal osteoporosis1
- Postreproductive health1
- Raloxifene1
- Screening1
- Selective estrogen receptor modulators1
- Sexuality1
- Tamoxifen1
- Vulvovaginal atrophy1
EMAS Position Statements and Clincial Guides
3 Results
- Review
Update on management of genitourinary syndrome of menopause: A practical guide
MaturitasVol. 82Issue 3p308–313Published online: July 24, 2015- Santiago Palacios
- Camil Castelo-Branco
- Heather Currie
- Velja Mijatovic
- Rossella E. Nappi
- James Simon
- and others
Cited in Scopus: 91The term genitourinary syndrome of menopause (GSM) emerged following a consensus conference held in May 2013. GSM is a more descriptive term than vulvovaginal atrophy (VVA) and does not imply pathology. However there are concerns that GSM is all encompassing and includes not only symptoms resulting from estrogen deficiency, but also those arising from the effects of ageing and other processes on the bladder and pelvic floor. Focusing on symptoms related to estrogen deficiency, the update provides a practical guide for health and allied health professionals on the impact of GSM on women and their partners, assessment, management and areas for future research. - Research Article
EMAS position statement: The ten point guide to the integral management of menopausal health
MaturitasVol. 81Issue 1p88–92Published online: February 10, 2015- Manuel Neves-e-Castro
- Martin Birkhauser
- Goran Samsioe
- Irene Lambrinoudaki
- Santiago Palacios
- Rafael Sanchez Borrego
- and others
Cited in Scopus: 73With increased longevity and more women becoming centenarians, management of the menopause and postreproductive health is of growing importance as it has the potential to help promote health over several decades. Women have individual needs and the approach needs to be personalised. The position statement provides a short integral guide for all those involved in menopausal health. It covers diagnosis, screening for diseases in later life, treatment and follow-up. - Research Article
EMAS clinical guide: Selective estrogen receptor modulators for postmenopausal osteoporosis
MaturitasVol. 71Issue 2p194–198Published online: November 24, 2011- Santiago Palacios
- Mark Brincat
- C. Tamer Erel
- Marco Gambacciani
- Irene Lambrinoudaki
- Mette H. Moen
- and others
Cited in Scopus: 17Osteoporosis and the resulting fractures are major public health issues as the world population is ageing. Various therapies such as bisphosphonates, strontium ranelate and more recently denosumab are available. This clinical guide provides the evidence for the clinical use of selective estrogen modulators (SERMs) in the management of osteoporosis in postmenopausal women.
